PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32615861-3	2021	The aim of this study was to characterize the degradation-controlled in vitro release kinetics of PTH from the thiol-ene hydrogels, in vivo hydrogel degradation in a subcutaneous implant model, and bone healing in a rat critical size bone defect.	ene	117-120	parathyroid hormone	Rattus norvegicus	98-101	
32615861-7	2021	Treatment of bone defects with the composite thiol-ene hydrogel-PPF scaffold, delivering either 3 or 10 microg of tethered PTH 1-84, was found to increase bridging of critical size bone defects, whereas treatment with 30 microg of tethered PTH resulted in less bone ingrowth into the defect area.	ene	51-54	parathyroid hormone	Rattus norvegicus	123-131	
32615861-7	2021	Treatment of bone defects with the composite thiol-ene hydrogel-PPF scaffold, delivering either 3 or 10 microg of tethered PTH 1-84, was found to increase bridging of critical size bone defects, whereas treatment with 30 microg of tethered PTH resulted in less bone ingrowth into the defect area.	ene	51-54	parathyroid hormone	Rattus norvegicus	123-126